US Post News
  • Home
  • Stocks Trading
  • Analyst Snapshot
  • Market Summary
  • Financial Scores
No Result
View All Result
  • Home
  • Stocks Trading
  • Analyst Snapshot
  • Market Summary
  • Financial Scores
No Result
View All Result
US Post News
No Result
View All Result
Home Market

Is Genius Sports Limited (GENI) a opportunity to investors?

January 25, 2023
in Market

Genius Sports Limited (NYSE:GENI) closed Tuesday at $4.83 per share, up from $4.45 a day earlier. While Genius Sports Limited has overperformed by 8.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, GENI fell by -23.94%, with highs and lows ranging from $7.09 to $2.20, whereas the simple moving average jumped by 27.32% in the last 200 days.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

On January 19, 2022, Credit Suisse started tracking Genius Sports Limited (NYSE: GENI) recommending Outperform. A report published by The Benchmark Company on November 24, 2021, Reiterated its previous ‘Buy’ rating for GENI. UBS also rated GENI shares as ‘Neutral’, setting a target price of $18 on the company’s shares in an initiating report dated October 11, 2021. Citigroup Initiated an Buy rating on October 11, 2021, and assigned a price target of $22. B. Riley Securities initiated its ‘Buy’ rating for GENI, as published in its report on September 10, 2021. Needham’s report from June 07, 2021 suggests a price prediction of $28 for GENI shares, giving the stock a ‘Buy’ rating. Goldman also rated the stock as ‘Buy’.

Analysis of Genius Sports Limited (GENI)

Further, the quarter-over-quarter increase in sales is 13.90%, showing a positive trend in the upcoming months.

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Genius Sports Limited’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -18.20% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.70, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and GENI is recording an average volume of 884.66K. On a monthly basis, the volatility of the stock is set at 6.27%, whereas on a weekly basis, it is put at 6.81%, with a gain of 13.38% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.75, showing growth from the present price of $4.83, which can serve as yet another indication of whether GENI is worth investing in or should be passed over.

How Do You Analyze Genius Sports Limited Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 46.69%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 35.20% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Are institutional investors increasing their holdings in GENI shares?

The recent increase in stakes in GENI appears to be a result of several institutional investors and hedge funds increasing their positions. Caledonia’s position in GENI has decreased by -0.73% in the first quarter. The company now owns 18,559,335 shares of the stock, with a value of $66.26 million, following the sale of -135,645 additional shares during the last quarter. Granahan Investment Management, L made another increased to its shares in GENI during the first quarter, upping its stake by 63.23%.

At the end of the first quarter, Massachusetts Financial Services increased its GENI holdings by 7.35% and now holds 4.0 million GENI shares valued at $14.28 million with the added 0.27 million shares during the period. GENI shares are owned by institutional investors to the tune of 35.20% at present.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

GAN Limited (GAN) can beat the pack with these strategies

January 13, 2023

Can you now get a good deal on Schmitt Industries Inc.’s shares?

January 3, 2023

Ocugen Inc. (NASDAQ:OCGN): It’s all about numbers this morning

January 9, 2023

“US Post News” – one of the oldest and most authoritative news sites in America. It was established in 1992, journalists, photographers, correspondents, researchers came to the publication from the editorial offices of regional newspapers, drama theater, etc. They had no training, and they gained experience and skill in the process of work.

Contact us: ceo@www.uspostnews.com

Catagories

  • Market Summary
  • Stocks Trading
  • Analyst Snapshot
  • Financial Scores

Company

  • Home
  • About US
  • Contact US

RECENT POSTS

  • ACM Research Inc. (ACMR) is an excellent investment, but the stock is overvalued/undervalued right now
  • Have you been able to find a good deal on Intellia Therapeutics Inc.’s shares?
  • A closer look at YPF Sociedad Anonima (YPF) is warranted

Copyright © 2022 US Post News

No Result
View All Result
  • About US
  • Contact US
  • Home

Copyright © 2022 US Post News

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?